Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study of SHR-A1811 in Subjects With Ovarian Cancer [Phase 3]
Phase 3 clinical trial evaluating SHR-A1811 for ovarian cancer, currently recruiting.
-
CLINICAL_TRIALS other · 2026-04-20Clinical Trial Update: Trastzumab Deruxtecan Versus SOC in Recurrent Ovarian That Progressed on Prior PARP Inhibitor Therapy [Phase 2]
Phase 2 trial comparing trastuzumab deruxtecan versus standard of care in recurrent ovarian cancer after progression on PARP inhibitors is c…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Study to Assess Prevalence of the Folate Receptor Alpha (FRa) in Adult Female Participants With Ovarian Cancer in Intercontinental (InterCon) Countries
This clinical trial update describes a study sponsored by AbbVie to assess the prevalence of Folate Receptor Alpha in adult women with ovari…
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Study of Radspherin® in Recurrent Ovarian Cancer Subjects With Peritoneal Carcinomatosis [Phase 1]
Phase 1 study of Radspherin in recurrent ovarian cancer with peritoneal carcinomatosis has completed.
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian Cancer [Phase 1]
Phase 1 study evaluating peposertib (M3814) in combination with standard chemotherapy for ovarian cancer, with expansions in high-grade sero…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study
This ClinicalTrials.gov update describes the CHANCES study, which investigates clonal hematopoiesis and therapy-emergent myeloid neoplasms i…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 trial evaluating orally administered MOMA-313 in adults with advanced or metastatic solid tumors; the study is currently active but …
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study of LY4337713 in Participants With FAP-Positive Solid Tumors [Phase 1]
A Phase 1 clinical trial update for LY4337713 in participants with FAP-positive solid tumors; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
A Mayo Clinic-sponsored clinical trial is evaluating methylated DNA markers to detect endometrial, ovarian, and cervical cancers, with recru…
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of AUR 109 in Patients With Colorectal, Ovarian, and Renal Cancers [Phase 2]
Phase 2 trial of AUR 109 in ovarian cancer, colorectal cancer, and renal cell carcinoma has been terminated.
-
CLINICAL_TRIALS other · 2026-04-17Clinical Trial Update: A Two-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Part B) Ovarian Cancer [Phase 3]
This Clinical Trial Update reports a two-part Phase 3 study of Sofetabart Mipitecan (LY4170156) in platinum-resistant and platinum-sensitive…
-
EMA approval · 2026-04-16EMA Authorised: Zolsketil pegylated liposomal (doxorubicin hydrochloride, liposomal) — Accord Healthcare S.L.U.
The EMA authorised Zolsketil pegylated liposomal doxorubicin for ovarian cancer, Kaposi sarcoma, and multiple myeloma. The Marketing Authori…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression [Phase 3]
Phase 3 trial comparing INCB123667 to investigator's choice chemotherapy in platinum-resistant ovarian cancer with Cyclin E1 overexpression …
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer [Phase 3]
A Phase 3 clinical trial is evaluating heated intraperitoneal chemotherapy followed by niraparib for Stage III/IV ovarian cancer, primary pe…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Secondary Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Recurrent Mucinous Ovarian Cancer (HI-MOC Study) [Phase 2]
A Phase 2 clinical trial (HI-MOC) evaluating secondary cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy for recur…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: A Study of Isoquercetin in People With Ovarian Cancer [Phase 2]
A Phase 2 clinical trial evaluating isoquercetin in patients with ovarian cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib [Phase 3]
Phase 3 rollover study of Olaparib for patients who have completed a prior oncology trial is active but not recruiting. The trial is sponsor…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women [NA]
A clinical trial update notes that the study evaluating the CA125 algorithm for early detection of ovarian cancer in low-risk women is curre…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103) [Phase 3]
A Phase 3 trial evaluating maintenance therapy with Sacituzumab Tirumotecan (MK-2870) versus standard of care in platinum-sensitive recurren…
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: Evaluating Cascade Communication Methods
A completed University of Pennsylvania clinical trial evaluating cascade communication methods for individuals with BRCA1 or BRCA2 mutations…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Spanish Decision Tool for Ovarian Cancer Maintenance Therapy [NA]
Clinical trial update about a Spanish decision tool to aid maintenance therapy decisions in ovarian cancer, currently in recruitment.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF [Phase 1]
Phase 1 study to evaluate serial PET/CT imaging with the novel radiotracer [18F] Fluorthanatrace for cancer imaging; currently recruiting ac…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Adavosertib Before Surgery in Treating Patients With Advanced High Grade Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [EARLY_Phase 1]
An early-phase Phase 1 trial evaluating Adavosertib before surgery in patients with advanced ovarian, fallopian tube, or primary peritoneal …
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating IACS-6274 with or without Bevacizumab and Paclitaxel in adults with advanced solid tumors; the study is cu…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Biobehavioral and Sociodemographic Characteristics of Long Term Survivors of Ovarian Cancer
This clinical trial update describes a study on the biobehavioral and sociodemographic characteristics of long-term survivors of ovarian can…